Pioglitazone hydrochloride

AD57 is an orally active multikinase inhibitor, inhibits RET , BRAF , S6K and Src , with greatly reduces mTOR activityIn VitroAD57 (0.2 nM) significantly inhibits the ptc &gt: dRet MEN2B lethality in the larva of Drosophila. AD57 (0.1 nM) enhances

AD57 is an orally active multikinase inhibitor, inhibits RET , BRAF , S6K and Src , with greatly reduces mTOR activityIn VitroAD57 (0.2 nM) significantly inhibits the ptc &gt: dRet MEN2B lethality in the larva of Drosophila. AD57 (0.1 nM) enhances

Application AG-205 has been used to investigate the neuroprotective effects of norgestrel on stressed photoreceptors. It has also been used to study the effect of blocking progesterone receptor membrane component 1 in 661W cells.

Application AG-205 has been used to investigate the neuroprotective effects of norgestrel on stressed photoreceptors. It has also been used to study the effect of blocking progesterone receptor membrane component 1 in 661W cells.

InformationAlpelisib (BYL719) is a potent and selectivePI3Kαinhibitor withIC50of 5 nM in a cell-free assay, and minimal effect on PI3Kβ/γ/δ. Phase 2.In vitroBYL719 inhibits the proliferation of breast cancer cell lines harboring PIK3CA mutations,

Androgen receptor antagonist 1 is an orally available full androgen receptor ( AR ) antagonist with an IC 50 of 59 nM Androgen receptor antagonist 1 (Compound 6) can be used in the synthesis of PROTAC AR degraders, which results 24% and 47 % AR

Androgen receptor antagonist 1 is an orally available full androgen receptor ( AR ) antagonist with an IC 50 of 59 nM Androgen receptor antagonist 1 (Compound 6) can be used in the synthesis of PROTAC AR degraders, which results 24% and 47 % AR

Androgen receptor antagonist 1 is an orally available full androgen receptor ( AR ) antagonist with an IC 50 of 59 nM Androgen receptor antagonist 1 (Compound 6) can be used in the synthesis of PROTAC AR degraders, which results 24% and 47 % AR

Androgen receptor antagonist 1 is an orally available full androgen receptor ( AR ) antagonist with an IC 50 of 59 nM Androgen receptor antagonist 1 (Compound 6) can be used in the synthesis of PROTAC AR degraders, which results 24% and 47 % AR

Androgen receptor antagonist 1 is an orally available full androgen receptor ( AR ) antagonist with an IC 50 of 59 nM Androgen receptor antagonist 1 (Compound 6) can be used in the synthesis of PROTAC AR degraders, which results 24% and 47 % AR

R-Bicalutimide is an inhibitor of the androgen receptor that exhibits anticancer chemotherapeutic activity. With other anti-androgens, R-bicalutimide decreases levels of Bcl-2, Bcl-XL, caspase-3, and PARP, induces apoptosis, and inhibits cell growth

R-Bicalutimide is an inhibitor of the androgen receptor that exhibits anticancer chemotherapeutic activity. With other anti-androgens, R-bicalutimide decreases levels of Bcl-2, Bcl-XL, caspase-3, and PARP, induces apoptosis, and inhibits cell growth